Cyclin C belongs to the cyclin family of proteins that control cell cycle transitions through activation of speci®c catalytic subunits, the cyclin-dependent kinases (CDKs). However, there is as yet no evidence for any role of cyclin C and its partner, cdk8, in cell cycle regulation. Rather, the cyclin C-cdk8 complex was found associated with the RNA polymerase II transcription machinery. The periodic degradation of bona ®de cyclins is crucial for cell-cycle progression and depends on the catalytic activity of the associated CDK. Here we show that endogenous cyclin C protein is quite stable with a half-life of 4 h. In contrast, exogenously expressed cyclin C is very unstable (half-life 15 min) and degraded by the ubiquitin-proteasome pathway. Co-expression with its associated cdk, however, strongly stabilizes cyclin C and results in a protein half-life near that of endogenous cyclin C. In stark contrast to data reported for other members of the cyclin family, both catalytically active and inactive cdk8 induce cyclin C stabilization. Moreover, this stabilization is accompanied in both cases by phosphorylation of the cyclin, which is not detectable when unstable. Our results indicate that cyclin C has apparently diverged from other cyclins in the regulation of its stability by its CDK partner. Oncogene (2001) 20, 551 ± 562.
Introduction
The cyclin family represents a conserved class of proteins, named originally according to their oscillation during the cell cycle (Evans et al., 1983) . Bona ®de cyclins tightly control cell cycle progression through sequential association/activation of serine-threonine kinases subunits called cyclin-dependent kinases (CDK), inducing phosphorylation of key substrates such as the pocket protein, pRb (Arellano and Moreno, 1997) . However, cyclin H-cdk7 (Nigg, 1996) and cyclin T-cdk9 complexes (Wei et al., 1998) , displaying alternate functions in transcription and DNA repair, have been also identi®ed (Lania et al., 1999) .
Human cyclin C cDNA was cloned together with cyclins D1 and E by functional complementation of a Saccharomyces cerevisiae (S. cerevisiae) mutant strain, lacking the three G1 phase cyclins, CLN1-3 (Lew et al., 1991) . The Drosophila melanogaster cyclin C orthologue was isolated by a similar approach (Lahue et al., 1991; Leopold and O'Farrell, 1991) . Even though distantly related to other cyclin family members, human and drosophila cyclin C proteins share a high degree of homology (72% identity), suggesting an important role, conserved through evolution. Based on the cloning strategy and the weak G1 phase preferential expression in HeLa cells, cyclin C was ®rst classi®ed as a G1 phase cyclin (Leopold and O'Farrell, 1991; Lew et al., 1991) . But in contrast to cyclins D1 and E, there is no clear evidence for any role of cyclin C in regulating progression through the cell cycle.
In S. cerevisiae, the cyclin C orthologue, Srb11, together with its associated protein kinase, Srb10, were ®rst isolated as extragenic suppressors of a RNA polymerase II C-terminal domain (CTD) truncation mutation (Liao et al., 1995) . Srb11 is highly homologous to human and drosophila cyclin C, with 28% identity and 58% similarity between the three proteins. The Srb10-Srb11 complex was then shown to be a component of the RNA polymerase II holoenzyme. Furthermore, in vivo galactose-induced transcription and in vitro CTD phosphorylation are aected by defects in the Srb10-Srb11 kinase activity, suggesting a role for this cyclin-kinase complex in transcriptional regulation (Hirst et al., 1999; Liao et al., 1995) .
In higher eucaryotes, cyclin C associates with a speci®c kinase, cdk8, which is closely related to the yeast Srb10 (Leclerc et al., 1996; Tassan et al., 1995) . As in S. cerevisiae, cyclin C and cdk8 are associated with RNA polymerase II in vivo (Leclerc et al., 1996; Rickert et al., 1996) , and display kinase activity towards the CTD of human RNA polymerase II in vitro . Although both cyclin Ccdk8 and the well-studied CTD kinase complex, cyclin H-cdk7, can phosphorylate the same amino-acid residue in the tandem repeats characteristic of the CTD, additional data point to functional dierences between the two kinases and suggest that cyclin C-cdk8 may have a speci®c role in transcriptional regulation through phosphorylation of distinct sites in RNA polymerase II (Rickert et al., 1999) . Indeed, cyclin Ccdk8 was found in various multiprotein complexes puri®ed from human HeLa cells, which were shown to regulate RNA polymerase II-dependent transcription both positively and negatively (Boyer et al., 1999; Cho et al., 1998; Gold et al., 1996; Gu et al., 1999; Maldonado et al., 1996; Sun et al., 1998) . Nevertheless, the role of cyclin C and cdk8 in transcriptional regulation is still unknown. In yeast, however, genetic approaches implicate the cyclin C-cdk8 complex homologue Srb11-Srb10 in the transcriptional control of several groups of genes. The Srb11-Srb10 kinase is essential for a normal transcriptional response to galactose induction in vivo (Liao et al., 1995) , but is also implicated in transcriptional repression induced by glucose (Balciunas and Ronne, 1995; Carlson et al., 1984; Kuchin et al., 1995) , by phosphate (Kuchin and Carlson, 1998) as well as in repression of meiotic genes (Kuchin et al., 1995; Strich et al., 1989; Surosky et al., 1994) . Since the cyclin C-cdk8 complex is strongly conserved through evolution, the data obtained in yeast suggest that this complex may display similar transcriptional control functions on the expression of speci®c genes in mammals and indicate that the C-type cyclins are part of the divergent cyclin subfamily that is implicated in transcription.
The control of cyclin presence is of major importance for the transient cyclin-CDK activity during cell cycle progression. For instance, cyclin E, A and B1 are expressed at particular stages of the cell cycle while cyclin D1 is induced after growth factor stimulation Matsushime et al., 1991; Pines and Hunter, 1990) . This dierential expression is regulated at both the mRNA and protein synthesis levels but also through protein stabilization. As a rule, cell cycle cyclins are unstable proteins and are stabilized by interaction with their cognate inactive CDK. Catalytic activity leads to rapid degradation of the cyclins by the ubiquitin-proteasome pathway, either by direct phosphorylation by their CDK partner, as is the case for yeast Cln cyclins and cyclin E, or by other kinases such as GSK-3b in the case of cyclin D1 (Clurman et al., 1996; Diehl et al., 1998; Lanker et al., 1996; Won and Reed, 1996; Yaglom et al., 1995) . Phosphorylation of the cyclins could induce dissociation from their CDK partner, which would be required for ubiquitination and degradation by the proteasome as was proposed for cyclin E (Clurman et al., 1996) . A notable exception is cyclin A that does not require phosphorylation by either cdc2 or cdk2 to be degraded (Yam et al., 2000) . Also, ubiquitination of free cyclin D1 and E seems to be independent of phosphorylation suggesting that distinct pathways of ubiquitination lead to degradation of free and CDK-bound cyclin D1 and E (Germain et al., 2000; Singer et al., 1999) . Taken together, these data indicate that the basal process regulating cyclin stability has been speci®cally adapted to the cell speci®c functions of each cyclin.
In contrast to the previously mentioned cyclins, protein levels and catalytic activity of cyclin C-cdk8 do not vary signi®cantly during cell cycle or after growth factor stimulation (Leclerc et al., 1996; Rickert et al., 1996; our unpublished results) . Therefore, it was of interest to investigate this cyclin's protein stability pro®le and its dependence on its cognate CDK. Here we show that similar to other cyclins, free cyclin C is an unstable protein and is rapidly ubiquitinated and degraded by the proteasome. However, cyclin C is stabilized by both catalytic active and inactive cdk8, resulting in a protein half-life similar to that of endogenous cyclin C. Moreover, stable cyclin C is phosphorylated independently of cdk8 catalytic activity, suggesting that the stability of cyclin C is regulated independently of the catalytic activity of its CDK partner. Taken together, our data describes a novel mechanism for cyclin protein stabilization.
Results

Cyclin C protein is stabilized by cdk8 kinase co-expression
In order to conditionally express cyclin C, the complete cDNA sequence of the human cyclin C was inserted into the tetracycline repressible pUHD10.3 plasmid (Gossen and Bujard, 1992) to create pUHD-cycC, which was transiently transfected into NIH3T3 ®bro-blasts. Surprisingly, we were not able to detect any exogenous cyclin C expression by immunoblotting analysis (Figure 1a , compare lane 2 with lane 1) despite a good anity of the anti-cyclin C antibody for a yeast-expressed cyclin C and high transfection eciencies as monitored by b-galactosidase vector cotransfection (data not shown). Similar results were obtained with various other murine and human cell lines (data not shown).
To determine whether the absence of immunodetection was not due to a weak recognition of the protein by the polyclonal antibody used, we constructed the pUHD-HAcycC vector to express the cyclin C protein fused at its N terminus to three in¯uenza virus hemagglutinin (HA) epitope tags. Again, no expression of a HA-tagged cyclin C protein was detected by immunoblotting analysis after transient transfection of pUHD-HAcycC (Figure 1a , compare lane 6 with lane 1).
Next, we tested whether the absence of detectable exogenous cyclin C expression could be due to inecient translation from the cloned cDNA. We therefore replaced the 5' non-coding sequence in pUHD-cycC by the corresponding sequence from a human cyclin D1 cDNA clone, which allows high cyclin D1 expression levels in transient transfection experiments (data not shown). The resulting construct (pUHD-5'cycC) was transfected in NIH3T3 cells and a clear exogenous cyclin C signal was now detected (Figure 1a , lane 4). This result indicates that the original 5' non-coding sequence of the cyclin C cDNA clone that we used is not able to eciently initiate translation in transfection experiments.
To test the in¯uence of cdk8 expression on cyclin C expression levels, we cloned the human cdk8 cDNA by reverse transcription-polymerase chain reaction (RT ± PCR) from human primary ®broblasts, and inserted it in the pUHD10.3 vector to create the pUHD-cdk8 expression vector. This vector was co-transfected in murine NIH3T3 cells, with the dierent cyclin C expression vectors as described above. Strikingly, high expression levels of non-tagged and HA-tagged cyclin C proteins were detected only when cdk8 was coexpressed ( Figure 1a , compare lane 3 with lane 2, and lane 7 with lane 6, respectively), at similar transfection eciencies ( Figure 1a , see b-galactosidase activity). Cdk8 co-expression also correlated with higher cyclin C steady-state levels when we used the pUHD-5'cycC plasmid, which allows detectable cyclin C expression when transfected alone (Figure 1a , compare lane 5 with lane 4). Importantly, no increase of endogenous cyclin C levels was associated with cdk8 over-expression (Figure 1a , see lane 7). Similar results were obtained in the dierent murine or primate cell lines that we tested (NIH3T3, Balbc/3T3, COS, 293, U2OS, HeLa, human primary ®broblasts), suggesting that the cdk8-dependent cyclin C accumulation is cell-type independent (Figure 1b and data not shown) .
To test the speci®city of cdk8-dependent expression of cyclin C, the HA-tagged cyclin C expression plasmid was co-transfected with dierent CDK expression plasmids in human U2OS cells, which we used in further experiments for their high transfection capacities. In this human cell line also, high cdk8-dependent HA-tagged cyclin C expression levels were detected in immunoblotting analysis (Figure 2 , lane 5). However, co-transfection of neither HA-tagged cdk2 nor cdk4 expression vectors led to higher cyclin C expression levels, despite transfection eciencies comparable to those obtained with the cdk8 expression vector ( Figure  2 , lanes 3 and 4). This result indicates that high levels of exogenous cyclin C expression cannot be induced by co-expression of all CDKs, and is thus most likely speci®cally dependent on co-expression of its associated kinase cdk8. , designed to allow expression of non-tagged (cycC) or hemagglutinin-tagged (HAcycC) cyclin C proteins respectively, or the empty vector (pUHD-10.3), together with a human cdk8 expression vector (pUHD-cdk8) where indicated (+). The b-galactosidase expression vector pUHG-16.3 was co-transfected as a control to monitor transfection eciency. Twenty-four hours after transfection, cell lysates were prepared and analysed for cyclin C and cdk8 expressions by SDS ± PAGE, followed by immunoblotting using the cyclin C antibody (cycC Ab) and the cdk8 antibody (cdk8 Ab), respectively. b-galactosidase activities (b-gal activity ± in arbitrary units) are indicated as transfection eciency control. (b) Human HeLa cells or murine NIH3T3 cells were transiently transfected with a HA-tagged cyclin C (HAcycC) expression plasmid (pUHD-HAcycC) or the empty vector (pUHD-10.3), together with a human cdk8 expression vector (pUHD-cdk8) where indicated (+). Twenty-four hours after transfection, cell lysates were prepared and analysed for cyclin C and cdk8 expressions by SDS ± PAGE and immunoblotting using the HA antibody (HA Ab) or the cdk8 antibody (cdk8 Ab), respectively Figure 2 In¯uence of various CDKs on steady state levels of exogenous cyclin C. Human U2OS cells were transiently transfected with the HA-tagged cyclin C (HAcycC) expression plasmid (pUHD-HAcycC) or the empty plasmid (pUHD10.3), together with cdk8, HA-tagged cdk2 (HA-cdk2) or HA-tagged cdk4 (HA-cdk4) expression vectors (pUHD-cdk8, pCMV-HAcdk2 and pCMV-HA-cdk4, respectively) where indicated (+). The pUHD-HA-I-SceI plasmid was co-transfected to express the HA-tagged I-SceI protein (HA-I-SceI), in order to monitor transfection eciencies. Twenty-four hours after transfection, cell lysates were prepared and analyzed for HA-tagged proteins and cdk8 expressions by immunoblotting experiments using the HA antibody (HA Ab) or the cdk8 antibody (cdk8 Ab), respectively Conversely, there is no variation of exogenous cyclin D1 expression levels in function of cdk8 expression levels (data not shown), suggesting that cdk8 may not be able to induce higher expression levels of all cyclins.
Taken together, these results suggest that the regulatory process described here is speci®c for the cdk8-cyclin C pair.
Cdk8-dependent regulation of cyclin C expression occurs at a post-transcriptional level
We next thought it was important to test whether enhanced cyclin C expression in the presence of cdk8 expression could be due to higher mRNA levels considering cdk8 is associated with several multiprotein complexes containing RNA polymerase II and at least in yeast, implicated in transcriptional regulation. To this end, we constructed the pUHDHAcycC-PAP reporter plasmid, designed to express both cyclin C and human placental alkaline phosphatase (PAP) proteins from the same mRNA molecule, owing to a viral internal ribosome entry sequence (IRES) placed between the two open reading frames. If cdk8 induces a higher mRNA expression and/or stability, a higher cyclin C expression level will be associated with a higher PAP expression level, detectable in a PAP activity assay. The pUHDHAcycC-PAP plasmid was introduced in U2OS cells, with or without co-transfection of the pUHD-cdk8 expression plasmid; a b-galactosidase expression plasmid was also co-transfected to monitor transfection eciency. Here again, high HA-tagged cyclin C levels correlated with cdk8 co-expression ( Figure 3a ). Note that this strong cyclin C signal was not due to a redistribution of the protein from a non-soluble cellular compartment to a soluble cell fraction when cdk8 is coexpressed since no cyclin C band was detected in the cell lysis pellet in absence of cdk8 co-expression ( Figure  3a , lane 4). Furthermore, no signi®cant variation of PAP enzymatic activity was observed with cdk8 coexpression, at similar transfection eciencies (data not shown). This strongly suggests that there was no variation of PAP-coding mRNA levels when cdk8 was co-expressed and consequently that cdk8 exerts its eect at a post-transcriptional level. In order to con®rm this hypothesis, a Northern blot analysis was conducted using b-galactosidase and cyclin C speci®c probes: no variation in HA-tagged cyclin C/PAP mRNA levels were detected with cdk8 co-expression ( Figure 3b , lanes 1/2 and 5/6). Taken together, these results indicate that cdk8 acts post-transcriptionally to increase cyclin C steady state levels.
Cdk8 induces stabilization of exogenous cyclin C, resulting in a protein with a half life similar to that of the endogenous protein
Our preceding results suggested that cyclin C expression is stimulated by cdk8 co-expression through protein stabilization. It was therefore important to determine cyclin C protein half-lives in the absence or presence of co-expressed cdk8. The half-life of the HAtagged cyclin C was determined in [ 35 S]methionine pulse/chase labeling of transfected U2OS cells. After immunoprecipitation and sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS ± PAGE) protein separation, the time-dependent decrease of the radioactively labeled protein indicated a short half-life of approximately 15 min for the HA-tagged cyclin C ( Figure 4a , lanes 1 ± 5). However, when cdk8 was coexpressed, the half-life of the HA-tagged cyclin C dramatically increased to nearly 4 h ( Figure 4a , lanes 8 ± 12). This result indicates that cdk8 can induce a strong stabilization of the normally short-lived HAtagged cyclin C protein.
Since the HA-tagged cyclin C protein displays 3 HA epitope tags at its N terminus, it was important to test whether these tags could have an impact on the cyclin C half-life. To determine the half-life of a non-tagged exogenous cyclin C, the same pulse/chase experiment as described above was done with U2OS cells after pUHD-5'cycC plasmid transfection with or without co-expression of cdk8. As was observed for the HA- Figure 3 Cdk8-dependent accumulation of exogenous cyclin C is controlled at a post-transcriptional level. Human U2OS cells were transiently transfected with a bicistronic HA-tagged cyclin C (HAcycC)/human placental alkaline phosphatase (PAP) expression vector (pUHD-HAcycC-PAP) or the control plasmid pUHD-PAP, together with a cdk8 expression vector (pUHDcdk8) where indicated (+). A b-galactosidase expression vector (pUHG16.3) was co-transfected as a transfection eciency control. Twenty-four hours after transfection, cells from each transfection point were harvested and divided into several samples, which were processed dierently. (a) Soluble cell extracts and pellets (corresponding to the non-soluble fraction of crude lysates recovered by centrifugation; see Materials and methods) were prepared and analysed for cyclin C and cdk8 expressions in immunoblotting analysis using the HA antibody (HA Ab) or the cdk8 antibody (cdk8 Ab), respectively. (b) Total RNAs were prepared and analysed by Northern blotting using 32 P-labeled, speci®c b-galactosidase (b-gal) and cyclin C DNA probes Cdk8-dependent stabilization of cyclin C protein C Barette et al tagged cyclin C protein, non-tagged cyclin C showed a very short half-life in the absence of cdk8 co-expression ( Figure 4b , lanes 1 ± 5), but when cdk8 was coexpressed, the half-life increased up to around 4 h ( Figure 4b , lanes 7 ± 11). The only weak variation of cdk8-dependent cyclin C expression levels that we observed with the pUHD-5'cycC plasmid under these conditions (see Figure 1a , compare lanes 4 and 5), is possibly due to inhibitory eects of high cyclin C levels on its synthesis from this chimeric construct. Since the presence of HA tags at the N-terminus of cyclin C protein had no eect on the stability of the protein we decided to use this HA-tagged construct for the sake of experimental convenience.
Finally, the half-life of the endogenous cyclin C was determined. A pulse/chase experiment was done, as described above, on exponentially growing U2OS cells. The half-life of the endogenous cyclin C appeared to be about 4 h (Figure 4c ), very similar to the half-life of the exogenously expressed cyclin C protein stabilized by cdk8 co-expression. This result is consistent with the fact that over-expressing cdk8 did not increase the endogenous cyclin C protein levels (see Figure 1c , lane 7) and further suggests that endogenous cyclin C is already stabilized by endogenous cdk8.
Cdk8-mediated cyclin C stabilization depends neither on the cdk8 kinase activity nor on a stable interaction with cdk8
CDK kinase activation was shown in other cases to lead to cyclin degradation. It was thus important to con®rm that exogenous cdk8 is catalytically active (Gold et al., 1996) , to exclude the possibility that cyclin C stabilization was due to a defective catalytic activity of exogenous cdk8. To monitor the kinase activity of the exogenous cyclin C-cdk8 complex, a kinase assay was performed after cdk8 immunoprecipitation from transfected cell lysates using glutathion-S-transferase-CTD (GST-CTD) recombinant protein as substrate. As shown in Figure 5a , the cdk8 speci®c kinase activity was increased when the wild-type cdk8 but not the kinase-dead mutant was expressed. This result con®rms that cyclin C can be stabilized by catalytically active cdk8.
To test the dependence of cyclin C stabilization on cdk8, we used a kinase de®cient mutant,`cdk8K 7 ', that is unable to phosphorylate the C-terminal domain of RNA polymerase II (Gold et al., 1996) . The HAtagged cyclin C expression plasmid was transfected into U2OS cells with or without co-expression of wild-type or mutant cdk8. At similar transfection eciencies (same levels of HA-tagged I-SceI control protein), similar levels of wild-type or mutant cdk8 proteins induced similar levels of HA-tagged cyclin C expression (Figure 5b, compare lanes 2 and 4). This result indicates that kinase-de®cient cdk8 has the same cyclin C stabilization capacity as the wild-type kinase and suggests that cdk8-dependent cyclin C stabilization is independent of the cdk8 kinase activity.
Secondly, we tested if a stable interaction between cyclin C and cdk8 was required for stabilization of the cyclin. A novel cdk8 mutant was designed based on published data dealing with the cdk4-cyclin D1 complex. A R55A/E56A double-point mutation in the PSTAIRE-like domain of cdk4 decreased its binding activity towards cyclin D1 by 85% without aecting its interaction with the CDK inhibitor p16 (Coleman et al., 1997) . A similar double point mutation (R65A/ E66A) was introduced in the PSTAIRE-like SACRE domain of cdk8 to generate the cdk8RE 7 mutant. To test the eect of the R65A/E66A mutant cdk8 on its interaction with cyclin C, co-immunoprecipitation experiments were performed on extracts of U2OS cells transfected with expression vectors for wild-type and S]methionine (300 mCi/ml). Cell lysates were prepared at various times after the chase and immunoprecipitation was carried out using the cyclin C (cycC) antibody (identi®cation of the speci®c cyclin C band was performed by immunoblot analysis with the cyclin C antibody, not shown). IVT cycC: 35 S-labelled cyclin C produced by in vitro transcription/ translation Oncogene Cdk8-dependent stabilization of cyclin C protein C Barette et al mutant proteins. The wild-type and kinase-de®cient cdk8 proteins were completely immunoprecipitated, inducing co-precipitation of most of HA-tagged cyclin C expressed in transfected cells (Figure 5c , lanes 3 ± 5 and 9 ± 11). In contrast, even though cdk8RE 7 was immunoprecipitated eciently, only a very small amount of HA-tagged cyclin C (less then 10%) was co-precipitated with this mutant cdk8, despite high expression levels of the cyclin C protein (Figure 5c , lanes 6 ± 8). These data indicate that the R65A/E66A double-point mutation in cdk8 greatly aects the capacity of cdk8 to bind cyclin C. However, the high levels of HA-tagged cyclin C co-expressed with this interaction-de®cient mutant suggest that cdk8RE 7 is still able to stabilize its cyclin partner (Figure 5c , lane 6). Immunoblotting analysis on total cell extracts con®rmed that similar levels of HA-tagged cyclin C were obtained when wild-type or mutant cdk8 proteins were expressed (with similar transfection eciencies) (Figure 5b, compare lanes 2 and 3) . This result indicates that interaction-de®cient cdk8 has the same cyclin C stabilization capacity as the wild-type kinase, suggesting that cdk8-dependent cyclin C stabilization may be independent of a stable cyclin C-cdk8 interaction. This latter suggestion is in agreement with the fact that up to 50% of exogenous cyclin C is not ) cdk8 expression vectors. Forty-eight hours after transfection, cell lysates were prepared and immunoprecipitation was performed using the anti-cdk8 antibody in order to monitor the cdk8-speci®c CTD kinase activity (see Materials and methods). (b) Cell lysates were separated by SDS ± PAGE and, after transfer on membrane, immunoblot analysis was done using the HA antibody (HA Ab) or the cdk8 antibody (cdk8 Ab). Pellet: corresponds to non-soluble part of crude lysates, recovered by centrifugation (see Materials and methods). (c) Immunoprecipitations were carried out using the anti-cdk8 antibody (cdk8 Ab). Non-processed lysates (TE: total extracts), immunoprecipitates (IP) and immunoprecipitation supernatants (SN) were separated by SDS ± PAGE for immunoblotting analysis using the HA antibody (HA Ab) or the cdk8 antibody. IPc: immunoprecipitation using a non-relevant antibody; N.S.: non-speci®c immunoprecipitate and its resulting supernatant bound to cdk8, as determined in immunoprecipitation experiments (data not shown). Furthermore, fractionation by gel ®ltration was performed on lysates from transfected cells expressing non-tagged or tagged cyclin C with wild-type or interaction-de®cient cdk8. The HA-tagged cyclin C and wild-type cdk8 were co-eluted in the same fractions (Figure 6a ) in agreement with their interaction capacity; in contrast, cyclin C only partially co-elutes with the interaction-de®cient cdk8, possibly re¯ecting the complex instability (Figure 6b) . Consequently, it cannot be excluded that a transient interaction between cyclin C and cdk8 is required for cyclin C stabilization.
Cyclin C that is stabilized by cdk8 coexpression is phosphorylated independently of cdk8 kinase activity Phosphorylation of G1 cyclins plays an important role in the cell cycle associated degradation of these proteins. We have shown that cyclin C is stabilized by coexpression of both catalytically active and inactive cdk8, suggesting that the kinase activity of its catalytic partner does not in¯uence the stability of cyclin C. It was nevertheless important to compare the phosphorylation states of free, unstable cyclin C with that of cdk8-stabilized protein. We therefore overexpressed unstable cyclin C by either transfecting large quantities of pUHD-5'cycC or we stabilized cyclin C by cotransfection of the cyclin C expressing plasmid with pUHD-cdk8 expressing either the wild-type, mutant RE 7 or K 7 cdk8. Transfected cells were incubated with [ 32 P]orthophosphate in order to label phosphorylated proteins. Strikingly, even when identical steady state levels of stable or unstable cyclin C were produced as determined by Western blotting, only cdk8-stabilized cyclin C is phosphorylated in a detectable manner and independently of the catalytic activity of the CDK (Figure 7 , compare lanes 8 ± 10 with 4). Thus, we conclude that cdk8-stabilized cyclin C is phosphorylated independently of its associated kinase activity.
Cyclin C is degraded via the ubiquitin-proteasome pathway
We have shown that exogenous cyclin C is a highly unstable protein when its kinase partner cdk8 is not coexpressed. It was therefore important to determine the pathway implicated in cyclin C degradation. U2OS cells were transfected with the HA-tagged cyclin C expression vector, and treated with cell penetrating protease inhibitors showing dierent inhibition speci®-cities (Lee and Goldberg, 1998). High HA-tagged cyclin C expression levels were detected in cells treated with MG101 and MG132, two proteasome inhibitors with relaxed speci®city since they also inhibit proteases like calpains, but also with lactacystin, a speci®c proteasome inhibitor (Figure 8a ). Moreover, calpain inhibitor 2, showing only weak proteasome inhibition activity, induced a faint but detectable stabilization of HA-tagged cyclin C (Figure 8a, lane 7) . In contrast, no HA-tagged cyclin C stabilization was induced in the presence of chloroquine, a lysosomal proteolysis inhibitor (Figure 8a , lane 5). These results indicate that cyclin C is mainly degraded by the proteasome pathway DeMartino and Slaughter, 1999) .
Proteins degraded by the proteasome pathway are frequently targeted to proteolysis by ubiquitination, Figure 6 Fractionation of cyclin C co-expressed with wild-type or interaction-de®cient cdk8. (a and b) Human U2OS cells were transiently transfected with (a) HA-tagged cyclin C (HAcycC) or (b) non-tagged cyclin C (5' cycC) expression vectors (pUHDHAcycC and pUHD-5' cycC, respectively), together with a (a) wild-type (cdk8) or (b) R65A/E66A mutant (cdk8RE) cdk8 expression vectors. Twenty-four hours after transfection, cell lysates were prepared and subjected to fractionation by Superose 6 gel chromatography. An aliquot of every other fraction was analysed for cyclin C and cdk8 expressions by SDS ± PAGE followed by immunoblotting using the cyclin C antibody (cycC Ab), the HA antibody (HA Ab) and the cdk8 antibody (cdk8 Ab), respectively. Fraction numbers and molecular weights (in kiloDaltons; kDa) of marker proteins are indicated above and below the blots, respectively Figure 7 Cdk8-independent phosphorylation of cyclin C stabilized by cdk8. Human U2OS cells were transiently transfected with the cyclin C (cycC) expression vector (pUHD-5' cycC), with cotransfection of wild-type (WT), R65A/E66A mutant (RE) or D173A mutant (K 7 ) cdk8 expression vectors, when indicated (+). Twenty-four hours after transfection, cells were 32 P-labelled; then cell lysates were prepared and immunoprecipitated using the anti-cyclin C antibody. Immunoprecipitates were separated on SDS ± PAGE and transfered to a membrane. Radioactive signals ( 32 P signal) were revealed by autoradiographic exposure. Then, Western blot analysis was performed using the anti-cyclin C antibody (cycC Ab) or the anti-cdk8 antibody (cdk8 Ab), followed by chemiluminescence revelation. P.C: preclearing (non-speci®c binding on Protein A-Sepharose gel) which consists of a reversible, covalent conjugation of multiple subunits of the 76 amino-acid long polypeptide ubiquitin (Hershko and Ciechanover, 1998) . To test if cyclin C can be ubiquitinated, the HA-tagged cyclin C was co-expressed with a HA-tagged ubiquitin, in the presence of MG101 to block proteasomal degradation. Cyclin C protein was immunoprecipitated by the anti-cyclin C antibody and HA-tagged molecules were revealed by immunodetection using the anti-HA antibody: a percentage of the molecules migrated more slowly in the gel when cyclin C and HA-ubiquitin were co-expressed, probably corresponding to multiubiquitinated forms of HA-tagged cyclin C (Figure 8b , lane 4). Thus, the HA-tagged cyclin C was mainly ubiquitinated in absence of cdk8 co-expression, although one cannot completely exclude co-precipitation of an unknown ubiquitinated protein with cyclin C. However, the HA-tagged cyclin C ubiquitinated forms and, more strikingly, their ratio towards nonubiquitinated forms appeared to be strongly reduced in the presence of cdk8 co-expression, likely re¯ecting the cdk8-dependent stabilization of cyclin C (Figure 8b,  compare lanes 4 and 5) .
Taken together, these data strongly suggests that cyclin C can be ubiquitinated and is mainly degraded by the proteasome dependent pathway, while cdk8 expression leads to cyclin C stabilization by inhibition of this ubiquitination.
Discussion
Since protein stability is an important factor in regulating the abundance of cyclins involved in cell cycle control, it was interesting to study this parameter for cyclin C, which appears to be more distantly related to the former cyclins. Indeed, despite the fact that human and drosophila cyclins C were ®rst isolated by a complementation screen in a conditional, G1-phase cyclins de®cient S. cerevisiae strain (Lahue et al., 1991; Leopold and O'Farrell, 1991; Lew et al., 1991) , there is as yet no clear evidence for any role of cyclin C in the regulation of cell cycle progression. Moreover, data reported elsewhere indicate that cyclin C-cdk8 complex levels and associated kinase activity do not vary during the cell cycle (Leclerc et al., 1996; Rickert et al., 1996) .
Here we show that the free exogenous cyclin C is an intrinsically unstable protein with a half-life of about 15 minutes and degraded by the ubiquitin-proteasome pathway (Koepp et al., 1999; Pagano, 1997) . Similar ®ndings have been reported for free cyclin D1 and E (Germain et al., 2000; Singer et al., 1999) that, like cyclin C, contain PEST sequences in their C-termini that could contribute to their relative short half-life, as was shown actually for D-type cyclins (Lew et al., 1991; Matsushime et al., 1991) . It is noteworthy that free, unstable cyclin C is not detectably phosphorylated and free cyclin A, D1 and E can be degraded without phosphorylation (Germain et al., 2000; Singer et al., 1999; Yam et al., 2000) . Thus, it can be assumed that unbound cyclins, in excess with respect to their associated kinases, are constitutively and rapidly targeted for degradation by the proteasome.
Our data further indicates that cyclin C is stabilized by co-expression of either catalytically active or inactive cdk8, most likely by the inhibition of cyclin C ubiquitination. This is a novel observation concerning degradation of cyclins. Indeed, it is generally assumed that cyclin binding contributes to CDK activation, which in turn induces cyclin degradation in a negative feedback control, resulting in the transient activation of these cyclin-CDK complexes in cell cycle regulation; thus, cyclin A and E are stabilized Figure 8 Ubiquitin-proteasome dependent degradation of cyclin C. (a) Human U2OS cells were transiently transfected with or without a HA-tagged cyclin C (HAcycC) expression plasmid (pUHD-HAcycC). Twenty-four hours after transfection, the cells were pooled and replated at similar density in seven 60 mm tissue culture dishes (to ensure equal HA-tagged cyclin C expression level in each dish); then the dishes were incubated for 6 h in presence of various cell penetrating protease inhibitors or the solvent DMSO as a control. Cell lysates were prepared and separated by SDS ± PAGE. After transfer on membrane, immunoblotting analysis was performed using the HA antibody (HA Ab). Fifty mM MG101, 50 mM chloroquine, 5 mM MG132, 50 mM calpain inh. 2 (calpain inhibitor 2), 10 mM lactacystin. (b) Human U2OS cells were transiently transfected with HA-tagged cyclin C (HAcycC), HA-tagged ubiquitin (HA-Ub) and/or cdk8 expression vectors (pUHD-HAcycC, pMT123, and pUHD-cdk8, respectively) where indicated (+). Twenty-four hours after transfection, cells were treated for 6 h with the non-speci®c proteasome inhibitor MG101 (50 mM), before lysis in presence of N-ethyl-maleimide (5 mM ®nal) to prevent degradation by isopeptidases. Immunoprecipitation was performed on cell lysates using the cyclin C antibody before immunoblotting analysis with the anti-HA antibody (HA Ab). Ig H.C.: immunoglobulin heavy chain Cdk8-dependent stabilization of cyclin C protein C Barette et al only by a catalytic inactive cdk2 mutant (Clurman et al., 1996; Won and Reed, 1996; Yam et al., 2000) . In addition, phosphorylation of the C-terminal threonine of CDK-bound cyclins D1 and E seems to be required for ubiquitination and degradation by the proteasome (Clurman et al., 1996; Diehl et al., 1997; Won and Reed, 1996) . More precisely, cdk2-bound cyclin E is directly phosphorylated by its CDK partner while cyclin D1 complexed to cdk4 is preferentially phosphorylated by GSK-3b to target these cyclins for proteolysis. In stark contrast, we show that the cdk8-stabilized cyclin C is phosphorylated, whereas the free, unstable cyclin is not. Moreover, cyclin C is phosphorylated when stabilized by either wild-type or kinase-dead cdk8. This raises the possibility that phosphorylation by a yet to be identi®ed kinase may be implicated in cyclin C stabilization. The absence of potential phosphorylation sites equivalent to the Cterminal threonine of cyclin E or D1 and also of potential serine-proline auto-phosphorylation sites present in the CTD of RNA polymerase II, further indicates that the regulation of cyclin C stability is dierent from that of the G1 cyclins and suggests that phosphorylation of cyclin C is not required for its degradation.
Moreover, we have some indications that a stable interaction of cyclin C with cdk8 is not required for its stabilization. Although both proteins eluate in the same fractions of gel exclusion chromatography, a signi®cant population of stabilized cyclin C does not coprecipitate with cdk8. Also, we have developped a novel cdk8 mutant displaying a very weak anity for cyclin C in immunoprecipitation experiments. Surprisingly, this interaction-de®cient mutant is still able to stabilize cyclin C to the same extent as the wild-type kinase. Thus, a tight cyclin C-cdk8 interaction does not seem to be required for cyclin C stabilization, suggesting that cyclin C is not protected from proteolysis by permanent binding to cdk8 per se, but perhaps by a cdk8-induced modi®cation.
Importantly, endogenous cyclin C has a half-life of about 4 h comparable to that of cdk8-stabilized exogenous cyclin C, suggesting that all the endogenous cyclin C is already stabilized by endogenous cdk8. The fact that overexpression of cdk8 does not increase endogenous cyclin C levels is further evidence. It is also noteworthy that cyclin C messenger RNA levels and probably also their translation are low, which would thus lead to a low production of cyclin C protein and their rapid stabilization by endogenous cdk8. Taken together, these data suggest that the catalytically active cdk8-induced cyclin C stabilization may be biologically relevant. A formal demonstration of this would require the reduction of endogenous cdk8 levels. Unfortunately, we were unable to achieve this by antisense approaches in either stable or transient transfections experiments (unpublished observations), suggesting that cdk8 and possibly cyclin C may be essential for cellular viability.
Similar to its mammalian orthologue, the S. cerevisiae cyclin C protein shows no signi®cant variation through the cell cycle and displays a rather long half-life (1.5 h) compared to the duplication time of yeast (Cooper et al., 1997) . However, when exposed to stress or sporulation conditions, it is rapidly degraded in an associated kinase-independent manner. Another yeast C-type cyclin, Ctk2, was also shown to be present in a highly unstable phosphorylated form, independently of its kinase partner, Ctk1 (Hautbergue and Goguel, 1999) . Taken together, these data indicate that yeast C-type cyclins are targeted to proteolysis independently of their associated kinases, and suggest that the cyclins C proteins may be intrinsically unstable. Based on the high homology between yeast and human cyclin C, it would be worthwhile to analyze whether human endogenous cyclin C may be targeted to degradation when exposed to stress conditions. We have found no variations of cyclin C levels after heat shock or UV irradiation (unpublished observations). However, extrapolation from yeast to human should be done with caution since, although human cyclin C interacts with the yeast cdk8 homologue in the twohybrid system, it does not complement all yeast cyclin C orthologue functions (Kuchin et al., 1995) .
To conclude, our results indicate that cyclin C has diverged from other cyclins not only in its function in cellular metabolism but also in the regulation of its stability by its CDK partner. Stabilization of cyclin C by catalytically active cdk8 is probably important to maintain a constitutive activity of cdk8 in contrast to cell cycle cyclins which need only to activate their CDK transiently. Further work will be required to determine the conditions in which the stability of cyclin C could be regulated and also the possible regulatory mechanisms involved.
Materials and methods
Cloning, plasmids constructs and mutagenesis
To construct pUHD-cycC, a BamHI cyclin C (cycC) cDNA fragment from pRC/CMV-cycC (kindly provided by P Hinds (Hinds et al., 1992) ) was inserted into the BamHI sites of the tetracycline-regulable expression vector pUHD-10.3 (Gossen and Bujard, 1992) . The pUHD-5'cycC vector was obtained by inserting a NotI ± NcoI 5' non-coding 150 bp sequence from a human cyclin D1 cDNA, upstream of the cyclin C cDNA open reading frame in the pUHD-cycC plasmid.
The pUHD-HAcycC plasmid contains three in¯uenza virus hemagglutinin epitope (HA) sequences placed upstream of the cyclin C cDNA cassette to allow expression of a HAtagged cyclin C (HAcycC). The bicistronic expression vector pUHD-HAcycC-PAP contains a human placental alkaline phosphatase (PAP) cDNA sequence downstream of the cyclin C cDNA sequence and separated by the internal ribosome entry sequence (IRES) of poliovirus to allow the coexpression of cyclin C and PAP from a single mRNA.
The complete human cdk8 cDNA sequence was obtained by reverse transcription-polymerase chain reaction (RT-PCR) from exponentially-growing normal human primary ®bro-blasts, using two oligonucleotide primers: 5'-gcgaattcctgtgacaatggacta and 5'-ccatgactcgacgtagagatctat. The resulting EcoRI-cdk8-XbaI fragment was inserted into the same sites of the tetracycline repressible expression vector pUHD-10.3, to create the pUHD-cdk8 plasmid.
To generate D173A and R65A/E66A point mutations in the cdk8 cDNA sequence, a PCR-based approach was chosen using internal oligonucleotide sequences containing the required point mutation(s): 5'-attgctgccatgggctttgcccgattattt and 5'-gcccatggcagcaatttttactcttcctcg for the D173A point mutation, 5'-gcatgtgcagcaatagcattacttcgagagc and 5'-gctattgctgcacatgccgacatagagatcc for the R65A/E66A double-point mutation. The SphI ± SalI wild-type fragment of cdk8 was replaced by the SphI ± SalI PCR fragment carrying the D173A mutation, to create the pUHD-cdk8-K 7 plasmid. Similarly, the EcoRI ± A¯II wild-type fragment of pUHDcdk8 was replaced by the EcoRI ± A¯II PCR fragment carrying the R65A/E66A double-mutation to yield the pUHD-cdk8-RE 7 plasmid; the pUHD-cdk8-K 7 /RE 7 , bearing the triple-point mutations, was generated by inserting the A¯II ± XbaI fragment of pUHD-cdk8-K 7 into the same sites of pUHD-cdk8-RE 7 plasmid. All constructs were veri®ed by DNA sequencing.
The pUHD-HA-I-SceI and pRSV-PAP plasmids were constructed in our laboratory and allow expression of HAtagged yeast endonuclease I-SceI and of the human placental alkaline phosphatase (PAP), respectively. The tetracycline repressible system plasmids pUHD-15.1 and pUHG-16.3 were described in (Gossen and Bujard, 1992) . The pCMV-HA-cdk2 and pCMV-HA-cdk4 were kindly given by C Sardet and allow expression of HA-tagged human cdk2 and cdk4, respectively. The pGCTD plasmid was a gift of R Dynan and allows expression of a recombinant GST-CTD fusion protein. The pMT123 plasmid, allowing expression of HA-tagged ubiquitin concatamer, was kindly provided by M Trier.
Antibodies
The polyclonal anti-cyclin C serum used in this study was developed in our laboratory by immunization of rabbits with a puri®ed recombinant glutathion-S-transferase human cyclin C fusion protein. The anti-cdk8 goat polyclonal antibody (C-19) was purchased from Santa Cruz Biotechnology, Inc.
The monoclonal anti-HA 12CA5 culture supernatant, obtained from hybridoma, was kindly provided by P Dariavach. The rabbit polyclonal anti-cyclin D1 49.3 serum was a generous gift from V Dulic.
Cell culture, transfection and metabolic labelling
The 293, NIH3T3, HeLa and U2OS murine and human cell lines were routinely grown in Dulbecco's modi®ed Eagle's medium (DMEM), supplemented with 10% fetal calf serum, penicilline (100 U/ml), streptomycin (100 mg/ml), at 378C in an atmosphere of 5% CO 2 .
Cells were plated at a density of 1610 5 cells per 35 mm tissue culture dish or 3610 5 cells per 60 mm tissue culture dish 24 h before being transfected. The NIH3T3, HeLa and 293 cells were transfected by calcium phosphate-mediated transfection (Sambrook et al., 1989) whereas the U2OS cells were transfected using FuGENE 6 (Roche), according to the manufacturer's instructions.
Cells were labelled with 
Protein analysis
After transfection and/or metabolic labelling, cells were rinsed twice in phosphate-buered saline and immediately scraped in ice-cold lysis buer (50 mM Tris, pH 8.0, 5 mM ethylenediaminetetraacetic acid (EDTA), 150 mM NaCl, 0.5% NP40, 2 mM phenylmethylsulfonyl¯uoride, 50 mg/ml aprotinin, 1 mM benzamidine, 5 mg/ml leupeptin, 10 mg/ml pepstatin A, 5 mM NaF, 0.1 mM Na 3 VO 4 ). Crude cell lysates were stored at 7808C, when not used immediately. Whole cell lysates were incubated 15 min on ice and centrifuged (14 000 r.p.m., 10 min, 48C) to recover the supernatants. The resulting lysates were diluted to equal protein concentrations before use (BCA Protein Assay, Pierce). Lysates aliquots normalized for total protein concentration and amount were used for immunoprecipitation. To recover speci®c anitybound proteins recognized by the goat polyclonal anti-cdk8 antibody, the rabbit polyclonal anti-cyclin C antiserum or the monoclonal anti-HA antibody, we used anti-goat immunoglobulins coupled to agarose, Protein A or Protein G immobilized on Sepharose beads, respectively. Brie¯y, aliquots were ®rst precleared by incubating with beads and non-relevant antibodies or pre-immune serum for 1 h at 48C with moderate agitation. The resulting supernatants were then incubated with the relevant antibody for 1 ± 2 h, at 48C with moderate agitation, before adding the beads for one additional hour. Then, the beads were washed three times with SNNTE buer (50 mM Tris, pH 7.4, 5 mM EDTA, 0.5 M NaCl, 1% Nonidet P-40, 5% sucrose) once with RIPA buer (50 mM Tris, pH 7.4, 150 mM NaCl, 1% Triton X100, 0.1% sodium dodecyl sulfate (SDS), 1% sodium desoxycholate), and resuspended in Laemmli's sample buer (LSB).
For gel fractionation, crude cell lysates in lysis buer were centrifuged (35 000 r.p.m., 15 min, 48C) and the resulting supernatants were loaded on a Superose 6 gel column (Pharmacia biotech). The elution was performed using elution buer (50 mM Tris, pH 7.5, 150 mM NaCl, 1 mM EDTA, 2 mM dithiothreitol (DTT)); fractions of 0.5 ml were collected every minute and subjected to Western blotting analysis.
For Western blotting and/or metabolic labelling analysis, LSB/protein samples were boiled for 5 min and proteins were resolved on 10% SDS ± PAGE. Proteins were electrotransfered (semi-dry) onto PVDF membranes (Immobilon P; Millipore) according to the manufacturer's instructions. Membranes were stained with Naphthol blue black before drying to visualize protein transfer. For metabolic labelling analysis, radioactive signals were revealed by membrane exposure on KODAK autoradiographic ®lms at room temperature for the appropriate times.
The rehydrated membranes were incubated with monoclonal anti-HA antibody hybridoma supernatant at 1/10 dilution, rabbit polyclonal anti-cyclin C antiserum or goat polyclonal anti-cdk8 antibody at 1/1000 dilution; after washing, membranes were incubated with horseradish peroxidase (HRP) conjugated anti-mouse immunoglobulin G (IgG) (Amersham), HRP-anti-rabbit IgG (Amersham) or HRP-anti-goat IgG (Sigma) respectively, at 1/5000 dilution. The blots were then revealed by enhanced chemiluminescence.
For cdk8 kinase assay, immunoprecipitations were performed using the anti-cdk8 antibody as described before, except that the RIPA wash was omitted. Instead, the Cdk8-dependent stabilization of cyclin C protein C Barette et al immunoprecipitates were washed once with the kinase buer (40 mM HEPES, pH 7.7, 7.5 mM Mg(OAc) 2 , 1 mM dithiothreitol (DTT), then incubated for 15 min in 20 ml of kinase buer supplemented with 1 mM ATP, 2 mCi of [d-
32
P]ATP and 500 ng GST-CTD. Kinase reactions were loaded on a 10% SDS ± PAGE gel and radioactive signals were quanti®ed using a Phosphorimager (Molecular Dynamics).
RNA analysis
Total RNAs were prepared by a two-step extraction method (Chomczynski and Sacchi, 1987) and resolved on a 1.2% agarose/formaldehyde gel before capillary-based transfer onto nylon membranes (Positive Membrane; Appligene) (Dautry et al., 1988) .
For cyclin C and b-galactosidase probe labeling, a BamHI fragment from pRC/CMV-cycC and a BamHI ± EspI fragment from pUHG-16.3 were 32 P-labelled using the Random Primers DNA Labelling System kit (Life Technologies) then puri®ed on a 1 ml Sephadex G-50 ®ne (Pharmacia Biotech) column.
Membranes were pre-hybridized with`Church' buer (0.5 M NaHPO 4 , 1% bovine serum albumin, 7% SDS, 1 mM EDTA; see Church and Gilbert, 1984) for 2 h at 658C, before overnight hybridization at 658C with the denatured probes in fresh`Church' buer. Then, after stringent washes, membranes were exposed on Kodak XOMAT AR autoradiographic ®lms for various times.
Enzymatic activity assays
For b-galactosidase activity assay, transfected cells were washed twice with phosphate-buered saline and scraped in ice-cold lysis buer (15 mM KH 2 PO 4 , pH 7.8, 8 mM MgCl 2 , 0.1% Triton X-100, 1 mM DTT). Crude cell lysates were centrifuged at 14 000 r.p.m. for 5 min at 48C to recover the supernatants which were used in a b-galactosidase activity colorimetric assay. Using 96-wells plates, 2 ml of magnesium solution (0.1 M MgCl 2 , 4.5 M b-mercaptoethanol), 44 ml of ONPG (o-nitrophenyl-b-D-galactopyranoside) 12 mM solution (in 0.1 M NaHPO 4 , pH 7.5), 20 ml of supernatant and 134 ml of 0.1 M NaHPO 4 pH 7.5 were added. After incubation for 30 min at 378C, the red-orange coloration intensity was quanti®ed at 450 nm.
For the PAP activity assay, transfected cells were washed with 154 mM NaCl, scraped on ice in isotonic buer (50 mM Tris, pH 7.5, 154 mM NaCl, 1 mM MgCl 2 ) and transferred to microcentrifuge tubes. Cell pellets were recovered by centrifugation (5000 r.p.m., 5 min), resuspended in 30 ml of isotonic solution and incubated for 30 min at 658C to inactivate endogenous phosphatases. After cooling to room temperature, 1 ml of reaction mix (5 mM p-nitrophenyl phoshate (Sigma) in 1 M diethanolamine, pH 9.85, 0.29 M NaCl, 0.53 mM MgCl 2 ) was added per tube and incubated for 1 h at 308C. Supernatants were recovered by centrifugation for 1 min at 12 000 r.p.m. and PAP activity was monitored by quanti®cation at 405 nm.
